Much of the work carried out by DTT is in support of the National Toxicology Program (NTP), an interagency partnership of the Food and Drug Administration, National Institute for Occupational Safety and Health, and NIEHS.
Office of Portfolio Strategy and Research Management
-
-
Warren Casey, Ph.D., D.A.B.T.
Director of Strategic Partnerships
-
Tel 984-287-3118
[email protected]
-
P.O. Box 12233
Mail Drop K2-16
Durham, NC 27709
Warren Casey, Ph.D., D.A.B.T., is the Director of Strategic Partnerships in the Office of Portfolio Strategy and Research Management within the Division of Translational Toxicology at the National Institute of Environmental Health Sciences (NIEHS). In this role, he identifies strategic opportunities with academic institutions, industry stakeholders, international organizations, and other federal agencies. Dr. Casey manages collaborative programs that promote innovative approaches for assessing human health risks associated with environmental exposure to harmful substances.
Throughout his distinguished career, Dr. Casey has held several key leadership positions, including Executive Director of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), Director of the NTP Interagency Center for the Evaluation of Toxicological Methods (NICEATM), and President of the Society of Toxicology's In Vitro and Alternative Methods Specialty Section. He also contributes his expertise as a scientific advisor on various national and international consortia, furthering the advancement of human-based toxicology.
Recent Publications
-
Hari A, AbdulHameed M, Balik-Meisner M, Mav D, Phadke D, Scholl E, Shah R, Casey W, Auerbach S, Wallqvist A, Pannala V. Exposure to PFAS chemicals induces sex-dependent alterations in key rate-limiting steps of lipid metabolism in liver steatosis.
Frontiers in toxicology.
2024;6:1390196.
[
AbstractHari A, AbdulHameed M, Balik-Meisner M, Mav D, Phadke D, Scholl E, Shah R, Casey W, Auerbach S, Wallqvist A, Pannala V. Exposure to PFAS chemicals induces sex-dependent alterations in key rate-limiting steps of lipid metabolism in liver steatosis. Frontiers in toxicology. 2024
]
-
Groff K, Allen D, Casey W, Clippinger A. Progress and Remaining Opportunities to Increase the Use of Animal-free Antibodies in the USA.
Alternatives to laboratory animals : ATLA.
2024 Sep;52(5):285-289.
[
AbstractGroff K, Allen D, Casey W, Clippinger A. Progress and Remaining Opportunities to Increase the Use of Animal-free Antibodies in the USA. Alternatives to laboratory animals : ATLA. 2024 Sep
]
-
Auerbach S, Casey W, Chang D, Cowden J, Davidson-Fritz S, Dean J, Devito M, Everett L, Harrill A, Hester S, Hughes M, Lambert J, Lizarraga L, Mezencev R, Patlewicz G, Thayer K, Thomas R, Vitense K, Wehmas L. Scientific Studies Supporting Development of Transcriptomic Points of Departure for EPA Transcriptomic Assessment Products (ETAPs)
US Environmental Protection Agency Center for Computational Toxicology and Exposure’s Reports.
2024 Mar [Epub ahead of print].
[
AbstractAuerbach S, Casey W, Chang D, Cowden J, Davidson-Fritz S, Dean J, Devito M, Everett L, Harrill A, Hester S, Hughes M, Lambert J, Lizarraga L, Mezencev R, Patlewicz G, Thayer K, Thomas R, Vitense K, Wehmas L. Scientific Studies Supporting Development of Transcriptomic Points of Departure for EPA Transcriptomic Assessment Products (ETAPs) US Environmental Protection Agency Center for Computational Toxicology and Exposure’s Reports. 2024 Mar
]
-
Auerbach S, Casey W, Chang D, Cowden J, Davidson-Fritz S, Dean J, DeVito M, Everett L, Harrill A, Hester S, Hughes M, Lambert J, Lizarraga L, Mezencev R, Patlewicz G, Thayer K, Thomas R, Vitense K, Wehmas L. Standard Methods for Development of EPA Transcriptomic Assessment Products (ETAPs)
US Environmental Protection Agency Center for Computational Toxicology and Exposure’s Reports.
2024 Mar [Epub ahead of print].
[
AbstractAuerbach S, Casey W, Chang D, Cowden J, Davidson-Fritz S, Dean J, DeVito M, Everett L, Harrill A, Hester S, Hughes M, Lambert J, Lizarraga L, Mezencev R, Patlewicz G, Thayer K, Thomas R, Vitense K, Wehmas L. Standard Methods for Development of EPA Transcriptomic Assessment Products (ETAPs) US Environmental Protection Agency Center for Computational Toxicology and Exposure’s Reports. 2024 Mar
]
-
Thomas R, Everett L, Harrill A, DeVito M, Brennan A, Chang D, Cowden J, Davidson-Fritz S, Dean J, Ford J, Hester S, Hughes M, Lambert J, Lizarraga L, Mezencev R, Macmillan D, Patlewicz G, Thayer K, Vitense K, Wehmas L, Reyner A, Auerbach S, Casey W. EPA Transcriptomic Assessment Product (ETAP) for Perfluoro-3-Methoxypropanoic Acid
US Environmental Protection Agency Center for Computational Toxicology and Exposure’s Assessments.
2024 Mar [Epub ahead of print].
[
AbstractThomas R, Everett L, Harrill A, DeVito M, Brennan A, Chang D, Cowden J, Davidson-Fritz S, Dean J, Ford J, Hester S, Hughes M, Lambert J, Lizarraga L, Mezencev R, Macmillan D, Patlewicz G, Thayer K, Vitense K, Wehmas L, Reyner A, Auerbach S, Casey W. EPA Transcriptomic Assessment Product (ETAP) for Perfluoro-3-Methoxypropanoic Acid US Environmental Protection Agency Center for Computational Toxicology and Exposure’s Assessments. 2024 Mar
]
More Recent Publications from PubMed